AI Article Synopsis

  • Patients with LCHAD deficiency exhibit severe symptoms such as low blood sugar, liver enlargement, and can lead to life-threatening conditions like sudden death.
  • Four unique mutations were identified in the mitochondrial trifunctional protein's alpha and beta subunits in four patients from three different families, indicated by high levels of 3-hydroxyacyl carnitines in their blood tests.
  • Genetic analysis showed specific mutations in the HADHA and HADHB genes, confirming the diagnoses and shedding light on the familial patterns of the disease, including cases of sudden infant death and serious complications like renal failure and myopathy.

Article Abstract

Patients with long-chain 3-hydroxyacyl coenzyme A dehydrogenase (LCHAD) deficiency manifest hypoketotic hypoglycemia, hepatomegaly, hypotonia, lactic acidemia, acute renal failure, cardiomyopathy, and sudden death. We describe four novel mutations of the alpha- and beta-subunits of the mitochondrial trifunctional protein in four patients from three unrelated families. Their plasma acylcarnitine profiles suggested the presence of LCHAD deficiency by demonstrating highly elevated 3-hydroxyacyl carnitines by tandem mass spectrometry (MS/MS). Patients 1 and 2 had siblings who had died of lactic acidemia during the neonatal period. These patients also manifested lactic acidemia and died in the neonatal period. Patient 3 had a family history of Reye-like syndrome. She exhibited acute renal failure, rhabdomyolysis, pericardial effusion, and myopathy at the age of 12 years. DNA analysis of patients 1 and 2 revealed homozygosity for a c.1689+2T>G mutation of the HADHA gene, resulting in the skipping of exon 16 with an in-frame 69-bp deletion. Patient 3 was a compound heterozygosity of the HADHB gene, N307D/N389D. Patient 4, a 25-month-old baby, manifested recurrent episodes of lethargy, metabolic acidosis, elevated liver enzymes, and dark urine from the age of 10 months. Mutation analysis of the HADHB gene of patient 4 identified compound heterozygosity of N114D/N307D.

Download full-text PDF

Source

Publication Analysis

Top Keywords

lactic acidemia
12
novel mutations
8
mitochondrial trifunctional
8
trifunctional protein
8
lchad deficiency
8
acute renal
8
renal failure
8
neonatal period
8
compound heterozygosity
8
hadhb gene
8

Similar Publications

Acidemia arises primarily from the accumulation of carbon dioxide or the loss of bicarbonate, leading to a pH decrease within the body, which can be fatal if severe and not promptly addressed. Metabolic acidemia occurs due to a loss of bicarbonate and can manifest through direct losses of bicarbonate via renal or gastrointestinal routes, or through the accumulation of anions such as lactic acid or ketoacids, leading to an anion gap metabolic acidosis. Many common etiologies for lactic acid and ketoacid generation exist, including medication-induced causes.

View Article and Find Full Text PDF

Background: Pathogen reduction technology (PRT)-treated apheresis platelets (APs) were returned without platelet swirl and with pH < 6.2. The platelet donor was taking prescription levothyroxine and metformin plus over-the-counter medications and supplements.

View Article and Find Full Text PDF
Article Synopsis
  • - Sepsis often causes high lactate levels and acute lung injury (ALI), with clinical studies linking elevated lactate to higher mortality in septic patients.
  • - Researchers found that during sepsis, lactate triggers changes in cold-inducible RNA-binding protein (CIRP) within macrophages, leading to the release of CIRP, which then interacts with pulmonary vascular endothelial cells (PVECs) to promote cell death pathways.
  • - The study reveals that lactate-induced CIRP release stabilizes Z-DNA binding protein 1 (ZBP1) in PVECs, exacerbating ALI through a cell death mechanism known as PANoptosis, emphasizing a potentially new target for treating sepsis-related complications. *
View Article and Find Full Text PDF

Definitions of adverse events associated with extracorporeal membrane oxygenation in children: results of an international Delphi process from the ECMO-CENTRAL ARC.

Lancet Child Adolesc Health

October 2024

Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA; Susan B Meister Child Health Evaluation and Research Center, Division of General Pediatrics, Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA. Electronic address:

Article Synopsis
  • ECMO is a complex and risky life support system that lacks standardized definitions for adverse outcomes, which hinders effective research and practices.
  • The ECMO-CENTRAL ARC was formed to create clear definitions for pediatric ECMO adverse events, using input from literature and a diverse expert panel.
  • After three rounds of surveys, 13 key adverse event definitions were established and unanimously agreed upon by the voting experts.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!